Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100820220120010053
Laboratory Medicine Online
2022 Volume.12 No. 1 p.53 ~ p.57
JAK2 V617F-Positive Acute Myeloid Leukemia: Clinicopathological Features of Two Cases
Lee Young-Eun

Lee Ji-Yun
Lee Jeong-Ok
Bang Soo-Mee
Hwang Sang-Mee
Abstract
Although the JAK2 V617F mutation is a common genetic basis for the BCR-ABL1-negative myeloproliferative neoplasm (MPN), it is very rarely observed in acute myeloid leukemia (AML) without antecedent MPN. While JAK2 V617F has a well-defined role as a driver mutation in MPNs, its role in de novo AML remains elusive. Here, we retrospectively identified two patients with JAK2 V617F-positive AML by next-generation sequencing. These patients were diagnosed with AML without a history of an antecedent MPN. The presence of dysmegakaryopoiesis and a non-complex karyotype were consistent with the features reported in previous cases. Concurrent mutations in JAK2 and MPL were identified in one of the patients. Presence of the JAK2 V617F mutation in AML does not imply a blast phase of an occult MPN and suggests a separate clinical entity.
KEYWORD
Acute myeloid leukemia, JAK2 mutation, Next-generation sequencing
FullTexts / Linksout information
Listed journal information
KoreaMed